This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| capricor | PERSON | 2 | π π π§² |
| duchenne | PERSON | 2 | π π π§² |
| accelerated approval | ORG | 1 | π π π§² |
| adcom | PRODUCT | 1 | π π π§² |
| adcoms | ORG | 1 | π π π§² |
| ai readiness starts | ORG | 1 | π π π§² |
| annex clinical corporation | ORG | 1 | π π π§² |
| biospace | ORG | 1 | π π π§² |
| bla | ORG | 1 | π π π§² |
| capricor therapeutics | PERSON | 1 | π π π§² |
| cfr | ORG | 1 | π π π§² |
| chaotic adcomm meeting | ORG | 1 | π π π§² |
| clinibiz | ORG | 1 | π π π§² |
| complete response letter for capricors biologics license application | ORG | 1 | π π π§² |
| controls | NORP | 1 | π π π§² |
| crl | ORG | 1 | π π π§² |
| ctgtac | ORG | 1 | π π π§² |
| deramiocel briefing | PERSON | 1 | π π π§² |
| facet life sciences | ORG | 1 | π π π§² |
| fda | ORG | 1 | π π π§² |
| fda accelerated | ORG | 1 | π π π§² |
| fda adcom shuns capricors | ORG | 1 | π π π§² |
| fda advisers vote against approval | ORG | 1 | π π π§² |
| fda advisory committee statistical analysis | ORG | 1 | π π π§² |
| fda advisory panel votes against approval of | ORG | 1 | π π π§² |
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 50.00 | π π° π§² |
|
|
1 | 50.00 | π π° π§² |
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-08-20 08:30:00+00 | Health |
|
The global health aid architecture is collapsing. The faith economy isn't | Analyze | Alaa Murabit | π neutral | 0.125 |
| 2026-08-04 07:38:14+00 | Science |
|
Capricorβs Duchenne AdCom Didnβt Fail on Science. It Failed on Statistics. | Analyze | Moe Alsumidaie | π neutral | 0.0249 |